NCT Number: NCT00473785
CVD Risk Reduction Trial
The purpose of this study is to provide lifestyle counselling for protective health behavior (exercise, diet, smoking cessation) to small groups (6-8 subjects) via teleconference. The sample includes individuals at elevated risk for cardiovascular disease (CVD) as well as individuals with established CVD. Our hypothesis is that telephone-based lifestyle counselling will (1) significantly increase protective lifestyle behavior (diet, exercise, smoke-free living) and (2) significantly reduce CVD risk factors at 6-month follow-up.
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–74 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Laurentian University / Sudbury and District Health Unit, Greater Sudbury, Ontario, Canada
About this study
COHRT was a 2 parallel-group randomized controlled trial that was designed to assess the efficacy of a community outreach strategy for cardiovascular disease (CVD) risk reduction among individuals at elevated risk for CV events. Randomization was stratified for diagnosis of CHD, type 1 or 2 diabetes, sex, and clinical depression, and blocked within our northern, rural, and urban recruitment sites. A 2X3 mixed factorial design was utilized: 2 Groups (Usual Care, UC/Lifestyle Counselling,LC) X 3 Intervals (Baseline, post-treatment, 6-month follow-up). All subjects received personal CVD risk factor feedback and standardized handouts on heart healthy lifestyle change. The LC group received 6 weekly 1-hour sessions of lifestyle counseling that was provided via teleconference in small groups (4-8 persons). Group facilitators were trained in a manualized protocol of motivational interviewing that was designed for CVD risk reduction through lifestyle change. Weekly supervision was also provided. We hypothesized that the LC group (vs. UC) would significantly increase protective health behavior (exercise, diet, smoke-free living) at post-treatment and 6-month follow-up. The secondary hypothesis was that LC would significantly reduce (1) CVD risk factors, (SBP, DBP, total cholesterol, LDL cholesterol), (2) 10-year absolute risk among subjects without CVD, and (3) significantly increase quality of life as measured by symptoms of depression, psychological stress, and social support.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 35 to 74 years of age,
- Diagnosis of CVD or Type 1 or 2 diabetes, or
- ≥2 of the following CVD risk factors:
- Confirmed diagnosis of hypertension,
- Dyslipidemia,
- Males aged ≥55 years/females aged ≥60 years,
- Family history of CHD or stroke;
- Current smoker, or
- BMI ≥ 27.
Exclusion criteria
- Diagnosis of clinically significant cardiac complications (e.g. arrhythmia, unstable angina) or a congenital cardiac condition;
- Major psychiatric illness (e.g. psychosis), history of alcohol or drug dependence within the previous year, or residence in a non-private setting.
Treatment and study plan
Individual CVD-risk factor feedback
BehavioralEducation for protective health behavior change
BehavioralPrimary outcomes
-
Psychometric assessment of change in exercise, diet and smoking
Time frame: Post-treatment and 6-month follow-up
Secondary outcomes
-
SBP, DBP, total cholesterol, HDL, LDL, triglycerides and 10-year absolute CVD risk
Time frame: 6-month follow-up
-
Psychometric assessment of symptoms of depression, psychological stress, and social support.
Time frame: post-treatment and 6-month follow-up
Sponsors and collaborators
Lead sponsor
University Health Network, Toronto
Other
Registry information
Official study title
Community Outreach Heart Health and Risk Reduction Trial
Acronym: COHRT
Important dates
- Study start
- 2002
- Study completion
- 2005
- First posted
- May 15, 2007
- Registry last updated
- May 15, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
NCT01778569
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsImpact of Elastin Mediated Vascular Stiffness on End Organs
NCT02840448
Aortic Stenosis, Supravalvular, Aortic Valve Disease
Bethesda, Maryland, United States
View Trial DetailsLinks Between Inflammation and Cardiometabolic Diseases
NCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsBlood Vessel Study
NCT01524549
Cardiovascular Disease, Cardiovascular Diseases
Research Triangle Park, North Carolina, United States
View Trial Details